Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP720256.RA5hP_7HznBpNbb3ZFn7X-41rxV5KJraZUG0QNQ5ZslWs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP720256.RA5hP_7HznBpNbb3ZFn7X-41rxV5KJraZUG0QNQ5ZslWs130_assertion type Assertion NP720256.RA5hP_7HznBpNbb3ZFn7X-41rxV5KJraZUG0QNQ5ZslWs130_head.
- NP720256.RA5hP_7HznBpNbb3ZFn7X-41rxV5KJraZUG0QNQ5ZslWs130_assertion description "[Dukes stages C and D were more frequent in primary tumors with loss of MSH3 expression (9 of 13), compared with tumors with retained expression (1 of 14; Fisher's exact test, P = 0.001), suggesting that MSH3 abrogation may be a predictor of metastatic disease or even favor tumor cell spread in MLH1-deficient colorectal cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP720256.RA5hP_7HznBpNbb3ZFn7X-41rxV5KJraZUG0QNQ5ZslWs130_provenance.
- NP720256.RA5hP_7HznBpNbb3ZFn7X-41rxV5KJraZUG0QNQ5ZslWs130_assertion evidence source_evidence_literature NP720256.RA5hP_7HznBpNbb3ZFn7X-41rxV5KJraZUG0QNQ5ZslWs130_provenance.
- NP720256.RA5hP_7HznBpNbb3ZFn7X-41rxV5KJraZUG0QNQ5ZslWs130_assertion SIO_000772 14871813 NP720256.RA5hP_7HznBpNbb3ZFn7X-41rxV5KJraZUG0QNQ5ZslWs130_provenance.
- NP720256.RA5hP_7HznBpNbb3ZFn7X-41rxV5KJraZUG0QNQ5ZslWs130_assertion wasDerivedFrom befree-20140225 NP720256.RA5hP_7HznBpNbb3ZFn7X-41rxV5KJraZUG0QNQ5ZslWs130_provenance.
- NP720256.RA5hP_7HznBpNbb3ZFn7X-41rxV5KJraZUG0QNQ5ZslWs130_assertion wasGeneratedBy ECO_0000203 NP720256.RA5hP_7HznBpNbb3ZFn7X-41rxV5KJraZUG0QNQ5ZslWs130_provenance.